AXIS-2: G-CSF Fails to Improve Recovery After StrokeAXIS-2: G-CSF Fails to Improve Recovery After Stroke
AX200, a novel neuroprotectant, was no better than placebo in improving functional outcomes in phase 2 testing. Medscape Medical News (Source: Medscape Today Headlines)
Celebrate Valentine’s Day with your pet
Will your cat or dog get a special treat, new sweater or unique keepsake this Valentine's Day? (Source: USATODAY.com Health)